Search results
Alzheimer’s biomarkers observed in young people with diabetes
MedicalNewsToday via AOL· 13 hours agoNew research shows that adolescents and young adults with type 1 or type 2 diabetes may be at higher...
Eisai initiates rolling Biologics License Application to US FDA for Leqembi® (lecanemab-irmb) for...
FOX 59 Indianapolis· 3 hours agoIn the US, Leqembi is indicated for the treatment of Alzheimer's disease (AD) in patients with Mild...
How Does Alzheimer’s Kill?
MedicineNet.com· 4 days agoAlzheimer's disease (AD) is a degenerative disease of the brain, resulting in memory loss, cognitive decline, and personality changes ...
Ozempic weight loss guide: Benefits and side effects
The Telegraph via Yahoo News· 20 hours agoIt seems as though Ozempic and other weight-loss jabs are everywhere – and the appetite for them shows no signs of slowing down - with the industry...
Unauthorized Living Season 1 Streaming: Watch & Stream Online via Netflix
COMINGSOON.net via Yahoo News· 1 hour agoThe show revolves around Nemo Bandeira, a powerful drug lord. After getting diagnosed with Alzheimer...
'I'm a Neurologist, and This Is My Go-To Dinner For Alzheimer's Prevention'
Parade via Yahoo News· 4 days agoNeurologist cooking dinner for Alzheimer's prevention Nearly 7 million Americans are living with ...
...Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast...
WFRV 5 Green Bay· 6 hours agoLEQEMBI is indicated for the treatment of Alzheimer's disease (AD) in patients with Mild Cognitive Impairment (MCI) or mild dementia ...
UPDATE 1-Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
Reuters via Yahoo Finance· 1 hour agoEisai and partner Biogen said on Tuesday that the Japanese drugmaker has begun submitting data on a rolling basis to the US health regulator for a marketing application of a subcutaneous form ...
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
Digital Journal· 9 hours agoTop-line data from first-in-human Phase 1a clinical trial of PMN310 as a treatment for Alzheimer’s disease on track for mid-2024CAMBRIDGE ...
LIVING WELL: New drug approved to treat Alzheimer’s Disease
FOX 16 Little Rock· 1 day agoThe FDA approved a new drug to treat Alzheimer’s Disease.